NexImmune Inc. (NEXI)
OTC: NEXI
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 04, 2025, 11:37 AM
NexImmune Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 2.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 114.91K | 228.51K | 265.54K | 400.23K | n/a | n/a | 326.19K | 397.06K | 348.86K | 234.58K | 240.71K | 216.17K | 174.33K |
Gross Profit | n/a | -114.91K | 1.89M | -265.54K | -400.23K | n/a | n/a | -326.19K | -397.06K | -348.86K | -234.58K | -240.71K | -216.17K | -174.33K |
Operating Income | -3.51M | -2.76M | -5.37M | -10M | -7.78M | -9.83M | -17.25M | -14.86M | -15.93M | -15.05M | -15.53M | -15.49M | -12.16M | -10.07M |
Interest Income | 31.87K | 14.79K | 45.44K | 154.9K | 223.32K | 274.74K | 320.31K | 226.75K | 84.22K | 33.09K | 22.19K | 19.86K | 6.85K | 3.61K |
Pretax Income | -2.33M | -3.08M | -5.36M | -9.85M | -7.57M | -9.57M | -16.89M | -14.73M | -15.86M | -15.02M | -15.53M | -14.65M | -12.18M | -8.55M |
Net Income | -2.33M | -3.08M | -5.36M | -9.85M | -7.57M | -9.57M | -16.89M | -14.6M | -15.8M | -14.99M | -15.53M | -14.65M | -12.18M | -8.55M |
Selling & General & Admin | 2.08M | 2.01M | 2.41M | 3.99M | 2.9M | 3.7M | 3.52M | 3.72M | 4.09M | 4.6M | 3.54M | 4.16M | 4.04M | 4.06M |
Research & Development | 647.37K | 629.11K | 2.27M | 6.01M | 4.88M | 6.12M | 13.73M | 11.14M | 11.84M | 10.45M | 11.99M | 11.33M | 8.12M | 6.01M |
Other Expenses | 779.44K | 97.01K | -36.27K | -13.32K | -5.17K | n/a | n/a | -100.03K | -19.05K | -2.58K | -15.62K | -19.09K | -25.97K | -722 |
Operating Expenses | 3.51M | 2.64M | 4.68M | 10M | 7.78M | 9.83M | 17.25M | 14.86M | 15.93M | 15.05M | 15.53M | 15.49M | 12.16M | 10.07M |
Interest Expense | n/a | n/a | 260.33M | n/a | n/a | n/a | n/a | 226.75K | n/a | 33.09K | n/a | 1.11K | 101.00 | 904.12K |
Selling & Marketing Expenses | -2.08B | -2.01B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.51M | 2.76M | 4.68M | 10M | 7.78M | 9.83M | 17.25M | 14.86M | 15.93M | 15.05M | 15.53M | 15.49M | 12.16M | 10.07M |
Income Tax Expense | -75.41K | -2.76B | -45.44K | -265.54K | -223.32K | n/a | n/a | -126.72K | -65.17K | -30.52K | -15.62K | -17.99K | -25.87K | 903.4K |
Shares Outstanding (Basic) | 1.38M | 1.25M | 1.07M | 1.05M | 1.04M | 1.04M | n/a | 976.41K | 914.85K | 913.47K | 913.16K | 908.45K | 905.12K | 903.17K |
Shares Outstanding (Diluted) | 1.38M | 1.25M | 1.07M | 1.05M | 1.04M | 1.04M | n/a | 976.41K | 914.85K | 913.47K | 913.16K | 908.45K | 905.12K | 903.17K |
EPS (Basic) | -1.69 | -2.46 | -5.03 | -9.4 | -7.25 | -9.17 | n/a | -14.96 | -17.27 | -16.41 | -17 | -16.12 | -13.46 | -9.46 |
EPS (Diluted) | -1.69 | -2.46 | -5.03 | -9.4 | -7.25 | -9.17 | n/a | -14.96 | -17.27 | -16.41 | -17 | -16.12 | -13.46 | -9.46 |
EBITDA | -2.65M | -2.64M | -3.46M | -7.62M | -7.24M | -9.56M | -16.63M | -14.53M | -15.53M | -14.7M | -15.3M | -15.25M | -11.95M | -7.47M |
EBIT | -2.73M | -2.76M | -4.68M | -10M | -7.78M | -9.83M | -16.89M | -14.86M | -15.93M | -15.05M | -15.53M | -14.65M | -12.18M | -7.64M |
Depreciation & Amortization | 75.41K | 114.91K | 228.51K | 265.54K | 400.23K | 263.77K | 264.09K | 326.19K | 397.06K | 348.86K | 234.58K | 240.71K | 216.17K | 174.33K |